A two-track protocol helped physicians select safe iodinated contrast media for patients with immediate hypersensitivity reactions, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.